炎症性肠病肺部表现的研究进展(5)
[18]Cohen M，Sahn SA. Bronchiectasis in systemic diseases[J].Chest，1999，116(4)：1063-1074.
[19]Moeser A，Pletz MW，Hagel S，et al.Lung disease and ulcerative colitis--mesalazine-induced bronchiolitis obliterans with organizing pneumonia or pulmonary manifestation of inflammatory bowel disease？[J].Z Gastroenterol，2015，53(9)：1091-1098.
[20]Gupta DC，Jenaw RK，Koolwal S，et al.A rare case of ulcerative colitis with diffuse parenchymal lung disease，spontaneous pneumomediastinum and subcutaneous emphysema[J].Indian J Chest Dis Allied Sci，2014，56(2)：109-111.
[21] Sarlos P，Szemes K，Hegyi P，et al.Steroid but not biological therapy elevates the risk of venous thromboembolic events in inflammatory bowel disease：a Meta-analysis[J].J Crohns Colitis，2018，12(4)：489-498.
[22] Weng MT，Park SH，Matsuoka K，et al.Incidence and risk factor analysis of thromboembolic events in East Asian patients with inflammatory bowel disease，a multinational collaborative study[J].Inflamm Bowel Dis，2018，24(8)：1791-1880.
[23]Pastorelli L，Dozio E，Pisani LF.Procoagulatory state in inflammatory bowel diseases is promoted by impaired intestinal barrier function[J].2015，2015(1-10)：189 341.
[24]Lu S，Wang L，Zhang W，et al.Ulcerative colitis with acute pleurisy：a case report and review of the literature[J].Medicine (Baltimore)，2017，96(30)：e7630.
[25]Mercadal NR，Wiebke EA.Recurrent pneumonia and colobronchial fistula from Crohn′s disease：infliximab alters and simplifies surgical management[J].Ann Gastroenterol，2012， 25(4)：361-364.
(收稿日期：2018-12-20 本文編辑：许俊琴), http://www.100md.com(刘宇 罗娟 缪应雷)
[19]Moeser A，Pletz MW，Hagel S，et al.Lung disease and ulcerative colitis--mesalazine-induced bronchiolitis obliterans with organizing pneumonia or pulmonary manifestation of inflammatory bowel disease？[J].Z Gastroenterol，2015，53(9)：1091-1098.
[20]Gupta DC，Jenaw RK，Koolwal S，et al.A rare case of ulcerative colitis with diffuse parenchymal lung disease，spontaneous pneumomediastinum and subcutaneous emphysema[J].Indian J Chest Dis Allied Sci，2014，56(2)：109-111.
[21] Sarlos P，Szemes K，Hegyi P，et al.Steroid but not biological therapy elevates the risk of venous thromboembolic events in inflammatory bowel disease：a Meta-analysis[J].J Crohns Colitis，2018，12(4)：489-498.
[22] Weng MT，Park SH，Matsuoka K，et al.Incidence and risk factor analysis of thromboembolic events in East Asian patients with inflammatory bowel disease，a multinational collaborative study[J].Inflamm Bowel Dis，2018，24(8)：1791-1880.
[23]Pastorelli L，Dozio E，Pisani LF.Procoagulatory state in inflammatory bowel diseases is promoted by impaired intestinal barrier function[J].2015，2015(1-10)：189 341.
[24]Lu S，Wang L，Zhang W，et al.Ulcerative colitis with acute pleurisy：a case report and review of the literature[J].Medicine (Baltimore)，2017，96(30)：e7630.
[25]Mercadal NR，Wiebke EA.Recurrent pneumonia and colobronchial fistula from Crohn′s disease：infliximab alters and simplifies surgical management[J].Ann Gastroenterol，2012， 25(4)：361-364.
(收稿日期：2018-12-20 本文編辑：许俊琴), http://www.100md.com(刘宇 罗娟 缪应雷)